Skip to content
healthcare.dev

Forfivo XL

NDC 24979-247, bupropion hydrochloride, tablet, film coated, extended release, from Upsher-Smith Laboratories, LLC.

Product NDC
24979-247
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022497
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24979-247 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE450 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
24979-247-062497902470630 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-247-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/80b01182-dc94-4990-8ebb-55c306d7e536

Use it

Look up 24979-247 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24979-247 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24979-247. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.